Conversely, the MAP3K1 gene’s association with Carboplatin (rank 1) seemed novel and yet, in a genome-wide association study on advanced NSCLC patients treated with this antineoplastic chemotherapy drug, a single nucleotide polymorphism in the DSCAM gene has been identified as a prognostic biomarker candidate [60]. The gene discussed is MAP3K1; the disease is non-small cell lung carcinoma.